BR112014004828A2 - método para preparação de uma composição compreendendo anticorpos altamente concentrados por ultrafiltração - Google Patents
método para preparação de uma composição compreendendo anticorpos altamente concentrados por ultrafiltraçãoInfo
- Publication number
- BR112014004828A2 BR112014004828A2 BR112014004828A BR112014004828A BR112014004828A2 BR 112014004828 A2 BR112014004828 A2 BR 112014004828A2 BR 112014004828 A BR112014004828 A BR 112014004828A BR 112014004828 A BR112014004828 A BR 112014004828A BR 112014004828 A2 BR112014004828 A2 BR 112014004828A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparing
- composition
- highly concentrated
- antibodies
- ultrafiltration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/14—Pressure control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/16—Flow or flux control
- B01D2311/165—Cross-flow velocity control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2315/00—Details relating to the membrane module operation
- B01D2315/14—Batch-systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2321/00—Details relating to membrane cleaning, regeneration, sterilization or to the prevention of fouling
- B01D2321/02—Forward flushing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/22—Controlling or regulating
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
resumo patente de invenção: "método para preparação de uma composição compreendendo anticorpos altamente concentrados por ultrafiltração". a presente invenção refere-se a um método para preparação de uma composição compreendendo anticorpos altamente concentrados pela ultrafiltração em modo de concentração em batelada tendo uma primeira taxa de alimentação constante e uma segunda taxa de alimentação controlada.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161530158P | 2011-09-01 | 2011-09-01 | |
US61/530,158 | 2011-09-01 | ||
PCT/JP2012/005536 WO2013031237A1 (en) | 2011-09-01 | 2012-08-31 | Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112014004828A2 true BR112014004828A2 (pt) | 2017-04-04 |
BR112014004828B1 BR112014004828B1 (pt) | 2021-03-09 |
BR112014004828B8 BR112014004828B8 (pt) | 2022-03-29 |
Family
ID=46982845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014004828A BR112014004828B8 (pt) | 2011-09-01 | 2012-08-31 | Métodos para preparação de composições compreendendo anticorpos ou proteínas concentradas por ultrafiltração |
Country Status (15)
Country | Link |
---|---|
US (3) | US9630988B2 (pt) |
EP (2) | EP2750784A1 (pt) |
JP (2) | JP6363017B2 (pt) |
KR (1) | KR101993488B1 (pt) |
CN (1) | CN103889555B (pt) |
AU (2) | AU2012303372A1 (pt) |
BR (1) | BR112014004828B8 (pt) |
CA (1) | CA2847302C (pt) |
IL (1) | IL231128B (pt) |
MX (1) | MX359235B (pt) |
MY (1) | MY182178A (pt) |
RU (1) | RU2638859C9 (pt) |
SG (1) | SG11201400260TA (pt) |
WO (1) | WO2013031237A1 (pt) |
ZA (1) | ZA201401184B (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0983767B1 (en) | 1997-03-21 | 2008-09-10 | Chugai Seiyaku Kabushiki Kaisha | Preventives or remedies for the treatment of multiple sclerosis containing antagonist anti-IL-6-receptor antibodies |
UA80091C2 (en) | 2001-04-02 | 2007-08-27 | Chugai Pharmaceutical Co Ltd | Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist |
GB2401040A (en) | 2003-04-28 | 2004-11-03 | Chugai Pharmaceutical Co Ltd | Method for treating interleukin-6 related diseases |
PE20091174A1 (es) | 2007-12-27 | 2009-08-03 | Chugai Pharmaceutical Co Ltd | Formulacion liquida con contenido de alta concentracion de anticuerpo |
DK2493922T3 (en) | 2009-10-26 | 2017-04-24 | Hoffmann La Roche | Process for preparing a glycosylated immunoglobulin |
TWI603738B (zh) | 2010-11-08 | 2017-11-01 | 建南德克公司 | 皮下投予抗-il-6受體抗體 |
DK2739157T3 (en) * | 2011-08-03 | 2018-01-08 | Prolacta Bioscience Inc | Microfiltration of human milk to reduce bacterial contamination |
JP6563910B2 (ja) | 2013-07-04 | 2019-08-21 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 血清サンプル中の抗薬物抗体を検出するための干渉抑制イムノアッセイ |
WO2016067177A1 (en) | 2014-10-27 | 2016-05-06 | Tmci Padovan S.P.A. | Improved filtration plant and relative method |
CN104673666A (zh) * | 2015-03-10 | 2015-06-03 | 华东理工大学 | 一种微型切向流过滤模拟装置 |
GB201600287D0 (en) * | 2016-01-07 | 2016-02-24 | Fujifilm Diosynth Biotechnologies Uk Ltd | Process |
JP7032381B2 (ja) | 2016-09-15 | 2022-03-08 | エヴォクア ウォーター テクノロジーズ エルエルシー | 超純水を処理するための方法及びシステム |
JP6399723B1 (ja) * | 2018-02-21 | 2018-10-03 | 株式会社グロータック | 自転車用変速操作装置 |
SG11202100391VA (en) | 2018-07-27 | 2021-02-25 | Arc Medical Devices Inc | Highly sulfated fucans for the treatment of fibrous adhesions |
KR20210044821A (ko) * | 2018-08-14 | 2021-04-23 | 브리스톨-마이어스 스큅 컴퍼니 | 개선된 단백질 회수 |
DE102019101745A1 (de) * | 2019-01-24 | 2020-07-30 | Putsch Gmbh & Co. Kg | Verfahren zum Betrieb einer Membranfilteranlage |
CN112512667B (zh) * | 2019-03-05 | 2022-12-06 | Arc医疗器械股份有限公司 | 用于粘性组合物的切向流过滤的***和方法 |
CN111018968B (zh) * | 2019-12-16 | 2021-07-27 | 兴盟生物医药(苏州)有限公司 | 一种通过超滤浓缩制备高浓度抗体制剂的方法 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6443305A (en) * | 1987-08-10 | 1989-02-15 | Fuji Photo Film Co Ltd | Cross flow type filtration process |
ATE129430T1 (de) * | 1989-07-14 | 1995-11-15 | Dow Chemical Co | Isotrope oder anisotrope mikroporöse membranen aus syndiotaktischem polystyrol und herstellungsverfahren. |
JPH0380921A (ja) * | 1989-08-24 | 1991-04-05 | Shinko Pantec Co Ltd | 膜濾過装置の運転方法 |
JPH0778025B2 (ja) | 1990-03-20 | 1995-08-23 | 日本赤十字社 | 免疫グロブリンgの製造方法 |
ES2134212T3 (es) | 1991-04-25 | 1999-10-01 | Chugai Pharmaceutical Co Ltd | Anticuerpo humano reconstituido contra el receptor de la interleuquina 6 humano. |
JP3091885B2 (ja) | 1991-07-05 | 2000-09-25 | 株式会社日立製作所 | 高温型二次電池及び電池モジュール |
AU744146B2 (en) | 1996-09-26 | 2002-02-14 | Chugai Seiyaku Kabushiki Kaisha | Antibody against human parathormone related peptides |
UA76934C2 (en) | 1996-10-04 | 2006-10-16 | Chugai Pharmaceutical Co Ltd | Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody |
KR100490507B1 (ko) * | 1996-10-10 | 2005-05-19 | 네오스 테크놀로지스, 인크. | 한외 여과, 역 삼투 및 나노 여과를 사용하는 탄수화물의 정제 |
CH692479A5 (de) | 1997-07-08 | 2002-07-15 | Bucher Guyer Ag | Querstrom-Filtrationsanlage sowie Verfahren zum Betrieb einer solchen Anlage. |
US6096872A (en) | 1997-10-14 | 2000-08-01 | Ortho Diagnostic Systems, Inc. | Viral clearance process |
BR9909382A (pt) | 1998-04-03 | 2000-12-05 | Chugai Pharmaceutical Co Ltd | Anticorpo humanizado contra o fator tissular humano (tf) e processo de produção de anticorpo humanizado |
DE19827473C1 (de) | 1998-06-19 | 1999-08-26 | Sartorius Gmbh | Verbesserte Crossflow-Filterkassetten |
TWI242043B (en) | 2000-03-10 | 2005-10-21 | Chugai Pharmaceutical Co Ltd | Polypeptide inducing apoptosis |
US6350382B1 (en) | 2000-06-23 | 2002-02-26 | Scilog, Inc. | Enhancing filtration yields in tangential flow filtration |
PT1324776E (pt) | 2000-10-12 | 2009-12-23 | Genentech Inc | Formulações de proteína concentradas de viscosidade reduzida |
EP1327680B1 (en) | 2000-10-20 | 2008-04-02 | Chugai Seiyaku Kabushiki Kaisha | Modified tpo agonist antibody |
WO2002092802A1 (en) * | 2001-05-14 | 2002-11-21 | Diversa Corporation | Novel methods of enzyme purification |
JP2005530845A (ja) | 2002-06-21 | 2005-10-13 | アイデック ファーマシューティカルズ コーポレイション | 抗体を濃縮するための緩衝化処方物およびその使用方法 |
EP1601788A4 (en) | 2003-02-24 | 2006-11-15 | Gtc Biotherapeutics Inc | TANGENTIAL FILTRATION METHODS AND APPARATUS THEREFOR |
TW200510532A (en) | 2003-07-15 | 2005-03-16 | Chugai Pharmaceutical Co Ltd | IgM production by transformed cell and method of quantifying the same |
EP1715764B1 (de) * | 2004-02-18 | 2010-12-15 | Bucher Unipektin AG | Verfahren zur diafiltration eines produktes und vorrichtung zur durchfuhrung des verfahrens |
US7410587B2 (en) * | 2004-08-03 | 2008-08-12 | Scilog, Inc. | Liquid handling for filtration and preparative chromatography |
US20060051347A1 (en) * | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
DOP2006000029A (es) * | 2005-02-07 | 2006-08-15 | Genentech Inc | Antibody variants and uses thereof. (variantes de un anticuerpo y usos de las mismas) |
US8741600B2 (en) | 2007-06-19 | 2014-06-03 | Asahi Kasei Kabushiki Kaisha | Method for separation of immunoglobulin monomers |
JP5099930B2 (ja) * | 2007-06-19 | 2012-12-19 | 旭化成株式会社 | 免疫グロブリン1量体の分離方法 |
AU2008332271C1 (en) | 2007-12-05 | 2014-04-24 | Chugai Seiyaku Kabushiki Kaisha | Anti-NR10 antibody and use thereof |
PE20091174A1 (es) | 2007-12-27 | 2009-08-03 | Chugai Pharmaceutical Co Ltd | Formulacion liquida con contenido de alta concentracion de anticuerpo |
RU2010151414A (ru) * | 2008-05-15 | 2012-06-20 | В.Хэлт Л.П. (Bs) | Способ получения фракций молока, обогащенных секреторными иммуноглобулинами |
JP2010047527A (ja) | 2008-08-22 | 2010-03-04 | Asahi Kasei Corp | 免疫グロブリン1量体の分離方法 |
ES2733346T3 (es) * | 2009-03-24 | 2019-11-28 | Wyeth Llc | Evaporación por membrana para generar medicamentos proteicos altamente concentrados |
JP2010248092A (ja) * | 2009-04-13 | 2010-11-04 | Asahi Kasei Corp | 免疫グロブリン1量体の分離方法 |
TWI505838B (zh) | 2010-01-20 | 2015-11-01 | Chugai Pharmaceutical Co Ltd | Stabilized antibody solution containing |
-
2012
- 2012-08-31 MY MYPI2014700440A patent/MY182178A/en unknown
- 2012-08-31 EP EP12769502.1A patent/EP2750784A1/en not_active Ceased
- 2012-08-31 SG SG11201400260TA patent/SG11201400260TA/en unknown
- 2012-08-31 KR KR1020147008464A patent/KR101993488B1/ko active IP Right Grant
- 2012-08-31 CN CN201280053636.1A patent/CN103889555B/zh active Active
- 2012-08-31 WO PCT/JP2012/005536 patent/WO2013031237A1/en active Application Filing
- 2012-08-31 JP JP2014510575A patent/JP6363017B2/ja active Active
- 2012-08-31 RU RU2014112230A patent/RU2638859C9/ru active
- 2012-08-31 BR BR112014004828A patent/BR112014004828B8/pt active IP Right Grant
- 2012-08-31 US US14/241,567 patent/US9630988B2/en active Active
- 2012-08-31 MX MX2014002253A patent/MX359235B/es active IP Right Grant
- 2012-08-31 EP EP17170961.1A patent/EP3235557A1/en active Pending
- 2012-08-31 AU AU2012303372A patent/AU2012303372A1/en not_active Abandoned
- 2012-08-31 CA CA2847302A patent/CA2847302C/en active Active
-
2014
- 2014-02-17 ZA ZA2014/01184A patent/ZA201401184B/en unknown
- 2014-02-24 IL IL231128A patent/IL231128B/en active IP Right Grant
-
2017
- 2017-03-06 JP JP2017041820A patent/JP6363751B2/ja active Active
- 2017-03-17 US US15/461,874 patent/US10590164B2/en active Active
- 2017-06-28 AU AU2017204395A patent/AU2017204395B2/en active Active
-
2020
- 2020-02-05 US US16/782,493 patent/US20200172569A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014004828A2 (pt) | método para preparação de uma composição compreendendo anticorpos altamente concentrados por ultrafiltração | |
MX356337B (es) | Anticuerpos contra csf-1r humano y sus usos. | |
BR112014002884A2 (pt) | composição para estimulação ovariana controlada | |
WO2015052106A3 (en) | Process for preparing polysiloxane-polycarbonate block cocondensates using a salt of a weak acid | |
PH12014502010A1 (en) | Bispecific antibodies against human tweak and human il17 and uses thereof | |
CL2016001154A1 (es) | Composiciones para prevenir o tratar alergias en infantes a partir de o alimentados por madres no secretoras. | |
UA114611C2 (uk) | Пестицидні композиції і способи, що їх стосуються | |
MX336682B (es) | Anticuerpos contra csf-1r humanos y usos de los mismos. | |
AR090973A1 (es) | Anticuerpos utiles para el diagnostico del cancer | |
BR112013022927A2 (pt) | composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição | |
EP3929217A3 (en) | Specific sites for modifying antibodies to make immunoconjugates | |
BR112014020826A2 (pt) | moduladores e métodos de uso | |
MY195289A (en) | Anti IL-36R Antibodies | |
NZ715201A (en) | Afucosylated anti-fgfr2iiib antibodies | |
BR112015012987A2 (pt) | composições compreendendo anticorpos anti-cd38 e lenalidomida | |
PH12016501366A1 (en) | Novel anti-baff antibodies | |
BR112014009866A2 (pt) | formulações de anticorpos e métodos | |
TN2013000378A1 (en) | Anti - sclerostin antibody crystals and formulations thereof | |
BR112013032771A2 (pt) | dipeptídio quimicamente e metabolicamente estável possuindo potente atividade bloqueadora de canais de sódio | |
WO2014145852A3 (en) | Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators | |
BR112013019520A2 (pt) | método para produção de 2,3-butanodiol por fermentação | |
GEP201706760B (en) | Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same | |
EA201300946A1 (ru) | Асимметричные мочевины и их медицинское применение | |
EA201491286A1 (ru) | Способ лечения потери костной массы альвеолярного отростка посредством применения антител к склеростину | |
BR112017004231A2 (pt) | processo para produzir um precipitado estável enriquecido em ficobiliproteínas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/08/2012, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REF. RPI 2618 DE 09/03/2021 QUANTO AO TITULO. |